当前位置: X-MOL 学术Liver Int. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Management, outcomes and survival of an Australian IgG4-SC cohort: The MOSAIC study
Liver International ( IF 6.7 ) Pub Date : 2021-08-14 , DOI: 10.1111/liv.15036
William Kemp 1, 2 , Ammar Majeed 1, 2 , Joanne Mitchell 1 , Avik Majumdar 3 , Edmund Tse 4 , Richard Skoien 5 , Daniel Croagh 6 , Anouk Dev 6 , Hugh Gao 6 , Martin Weltman 7 , Philip Craig 8 , Katherine Stuart 9 , Wendy Cheng 10 , Simon Edmunds 10 , Eric Lee 11 , Siddharth Sood 12 , Andrew Metz 12 , Alexander Thompson 13 , Marie Sinclair 14 , Lauren Beswick 15 , Amanda Nicoll 16 , Stephen Riordan 17 , Alicia Braund 18 , Kate Muller 19 , Gerry MacQuillan 20 , Neomal Sandanayake 21 , Nicholas Shackel 22 , Stuart Keith Roberts 1, 2
Affiliation  

IgG4 sclerosing cholangitis (IgG4-SC) is the biliary component of the multisystem IgG4-related disease. We aimed to investigate the clinical features, demographics, treatment response and outcomes of IgG4-SC in a large Australian cohort.

中文翻译:

澳大利亚 IgG4-SC 队列的管理、结果和生存:MOSAIC 研究

IgG4 硬化性胆管炎 (IgG4-SC) 是多系统 IgG4 相关疾病的胆道成分。我们旨在调查澳大利亚大型队列中 IgG4-SC 的临床特征、人口统计学、治疗反应和结果。
更新日期:2021-08-14
down
wechat
bug